Study Talazoparib Patients Breast Cancer Advanced Or Has Spread
A Study of Talazoparib in Patients with Breast Cancer That is Advanced or Has Spread
A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673) Administered to Germline BRCA Mutation Subjects With Locally Advanced and/or Metastatic Breast Cancer (ABRAZO Study)